comparemela.com
Home
Live Updates
Unity Biotechnology : Phase 2 ENVISION Program Update Call Presentation : comparemela.com
Unity Biotechnology : Phase 2 ENVISION Program Update Call Presentation
Arshad M. Khanani MD, MA, FASRS Director of Clinical Research at Sierra Eye Associates
Anirvan Ghosh, CEO Jamie Dananberg, CMO Lynne Sullivan, CFO
... | March 27, 2023
Related Keywords
Jamie Dananberg
,
Anirvan Ghosh
,
Arshadm Khanani
,
Lynne Sullivan
,
Exchange Commission On
,
Drug Administration
,
Nasdaq
,
Unity Biotechnology Inc
,
Clinical Development Plan
,
Exchange Commission
,
Clinical Research
,
Sierra Eye
,
Unity Biotechnology
,
Study Data
,
Disease Pathology
,
Nc Stock Exchange
,
News
,
Information
,
Press Release
,
Irshad
,
Dhanani
,
Ohasrs
,
Director
,
F
,
Linical
,
Research
,
It
,
Sierra
,
Eye
,
Nirvan
,
Ceo
,
Jamie
,
Imo
,
Ynne Ubx Us91381u2006
,
comparemela.com © 2020. All Rights Reserved.